Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users
Authors:
- 27 February 2008
- journal article
- review article
- Published by Taylor & Francis in Journal of Addictive Diseases
- Vol. 27 (2) , 75-82
Abstract
HCV and HIV infections are very common among injection drug users (IDUs). It is well known that 80–90% of HIV-infected IDUs are also infected with HCV. Furthermore, patients with HCV/HIV co-infection are at a higher risk of progressing to end-stage liver disease, namely cirrhosis. Even though there is increasing global awareness of HCV/HIV co-infection and extended therapeutic programs for this infected population, little is known about the HCV/HIV pathophysiology that mediates the rapid progression to hepatic disease. Liver disease caused by HCV/HIV co-infection is characterized by inflammation and cell-death. Recent reports suggest that the HIV and HCV envelope proteins may induce apoptosis and inflammation in hepatocytes via a novel pathway involving collaborative signaling. Moreover, HCV/HIV co-infection may also alter the cytokine production in vivo. Further studies to elucidate the molecular mechanisms of HCV and HIV-mediated pathogenesis will help in the development of therapeutic strategi...Keywords
This publication has 88 references indexed in Scilit:
- Intrahepatic cytokine expression is downregulated during HCV/HIV co-infectionJournal of Medical Virology, 2005
- Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus CoinfectionThe Journal of Infectious Diseases, 2005
- Treatment of Opioid Dependence and Coinfection with HIV and Hepatitis C Virus in Opioid- Dependent Patients: The Importance of Drug Interactions between Opioids and Antiretroviral AgentsClinical Infectious Diseases, 2005
- The origin of quasispecies: cause or consequence of chronic hepatitis C viral infection?Journal of Hepatology, 2005
- Management and Treatment of Injection Drug Users with Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus CoinfectionSeminars in Liver Disease, 2005
- The magnitude and breadth of hepatitis C virus–specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1Blood, 2005
- Liver biopsy in hepatitis CJournal of Hepatology, 1999
- EASL International Consensus Conference on Hepatitis CParis, 26–27 February 1999Consensus StatementJournal of Hepatology, 1999
- Serum levels of soluble Fas antigen in chronic hepatitis C patientsJournal of Hepatology, 1998
- Seroprevalence of Hepatitis A, B, C, and D Markers and Liver Function Abnormalities in Intravenous Heroin AddictsJournal of Addictive Diseases, 1995